Management of Tachybrady Arrhythmia
Understanding Tachybrady Syndrome
- Tachybrady syndrome describes a subset of symptomatic sinus node dysfunction characterized by alternating periods of fast heart rates and slow sinus rates or pauses, often causing recurrent syncope or presyncope secondary to transient asystolic pauses 1
- The severity of symptoms often correlates with the length of the pause, and the pathophysiologic link between sinus node dysfunction and atrial fibrillation remains incompletely understood 1
Diagnostic Approach
- Correlation between symptoms and bradycardia is considered the "gold standard" of diagnosis, and documentation of the arrhythmia with 12-lead ECG, 24-hour Holter monitoring, event or wearable loop recorders, or implantable loop recorders is recommended 2, 3
Management Algorithm
- For patients with tachybrady syndrome, permanent pacing is reasonable to increase heart rate and reduce symptoms attributable to bradycardia, while allowing for the use of medications to control tachyarrhythmias 1, 4
- The American College of Cardiology recommends evaluating for reversible causes first, such as reviewing and potentially adjusting medications that may exacerbate bradycardia, and assessing for electrolyte abnormalities or other metabolic disorders 2, 5, 6
- For symptomatic bradycardia with hemodynamic compromise, atropine 0.5-1 mg IV or temporary transcutaneous pacing may be considered, with the American College of Cardiology recommending atropine as a temporary measure to increase sinus rate 2, 5
- Permanent pacing indications include patients with symptoms directly attributable to bradycardia, patients with tachy-brady syndrome and symptoms attributable to bradycardia, and when essential pharmacologic therapy for tachyarrhythmias cannot be continued due to bradycardia 1, 4, 5
- Atrial-based pacing is recommended over single chamber ventricular pacing, with dual chamber or single chamber atrial pacing recommended in patients with intact atrioventricular conduction 5
Potential Pitfalls
- Atropine should not be used to treat sinus bradycardia in patients who have undergone heart transplant without evidence of autonomic reinnervation, according to the American College of Cardiology 2
- Abrupt withdrawal of beta-agonists can unmask underlying sinus node dysfunction or conduction disorders 7
Pacemaker Selection for Tachy-Brady Syndrome
Primary Indication for Pacing
- The American College of Cardiology recommends permanent pacing in patients with tachy-brady syndrome who have symptoms attributable to bradycardia, to increase heart rate and reduce symptoms from hypoperfusion, with a Class IIa recommendation 8, 9
Optimal Pacing Mode Selection Algorithm
- The American Heart Association suggests that dual-chamber (DDD/DDDR) or single-chamber atrial (AAI/AAIR) pacing is recommended over ventricular pacing in patients with intact AV conduction and no evidence of conduction abnormalities, with a Class I, Level B-R recommendation 8, 10, 11
- Atrial-based pacing provides a lower incidence of atrial fibrillation compared to ventricular pacing, according to the American College of Cardiology 10, 11
- Dual-chamber systems offer the advantage of backup ventricular pacing if AV conduction deteriorates over time, as stated by the Heart Rhythm Society 8
Programming Considerations for Dual-Chamber Devices
- The European Society of Cardiology recommends programming the device to minimize ventricular pacing, to avoid the deleterious effects of unnecessary right ventricular pacing, with a Class IIa, Level B-R recommendation 8, 9, 10
- This prevents pacemaker syndrome and reduces the risk of heart failure from ventricular dyssynchrony, according to the American Heart Association 11
Clinical Evidence Supporting Atrial-Based Pacing
- Four major randomized controlled trials compared atrial-based pacing (AAI/DDD) versus ventricular pacing (VVI) in sinus node dysfunction, and found a reduction in new-onset atrial fibrillation with atrial-based pacing, as reported by the American College of Cardiology 10, 11
Practical Implementation
- The American College of Cardiology states that the dual-chamber approach is particularly advantageous in tachy-brady syndrome because it allows aggressive antiarrhythmic drug therapy to control tachyarrhythmias without concern for drug-induced bradycardia 12
Common Pitfall to Avoid
- The Heart Rhythm Society advises against using single-chamber atrial pacing (AAI) in patients who may develop transient AV block, as this can occur in tachy-brady syndrome, and recommends dual-chamber systems for safety 13